Viewing Study NCT02357420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-02-21 @ 6:36 PM
Study NCT ID: NCT02357420
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2015-01-29
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
Sponsor: Allergan
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus View
None Diabetes Mellitus Complications View
None Gastroparesis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus View
None Delayed Gastric Emptying View
None Vomiting View
None Gastroparesis View
None Gastrointestinal Motility Disorder View